ProKidney Corp. (PROK) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PROK Revenue Growth
PROK Revenue Analysis (2019–2025)
As of May 8, 2026, ProKidney Corp. (PROK) generated trailing twelve-month (TTM) revenue of $893,000, reflecting explosive growth of +196.1% year-over-year. The most recent quarter (Q4 2025) recorded $225,000 in revenue, up 3.7% sequentially.
Looking at the longer-term picture, PROK's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $893,000 in 2025, representing a new all-time high.
When compared to Healthcare sector peers including FATE (-51.2% YoY), NTLA (+16.9% YoY), and BEAM (+108.0% YoY), PROK has outperformed the peer group in terms of revenue growth. Compare PROK vs FATE →
PROK Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PROKCurrent | $893,000 | +196.1% | - | -18477.8% | |
 FATE | $7M | -51.2% | -26.7% | -2222.4% | |
 NTLA | $68M | +16.9% | +3.1% | -651.7% | |
 BEAM | $140M | +108.0% | +466.3% | -274.6% | |
 RGEN | $738M | +17.4% | +15.0% | 8.1% |
PROK Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $893K | +1075.0% | $-4,829,000 | -540.8% | $-165,007,000 | -18477.8% |
| 2024 | $76K | - | $76K | 100.0% | $-183,676,000 | -241678.9% |
| 2023 | $0 | - | $0 | - | $-151,522,000 | - |
| 2022 | $0 | - | $0 | - | $-153,007,000 | - |
| 2021 | $0 | - | $0 | - | $-55,110,000 | - |
| 2020 | $0 | - | $0 | - | $-27,024,000 | - |
| 2019 | $0 | - | $0 | - | $-79,380,000 | - |
See PROK's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PROK Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PROK vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPROK — Frequently Asked Questions
Quick answers to the most common questions about buying PROK stock.
Is PROK's revenue growth accelerating or slowing?
PROK revenue is accelerating at +196.1% year-over-year, exceeding the 5-year CAGR of N/A. TTM revenue reached $893000.00. Growth momentum has increased versus prior periods.
What is PROK's long-term revenue growth rate?
ProKidney Corp.'s 5-year revenue CAGR of N/A reflects the sustained expansion pattern. Current YoY growth of +196.1% is above this long-term average.
How is PROK's revenue distributed by segment?
PROK reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.